The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Porcine Epidemic Diarrhea Vaccines-Global Market Insights and Sales Trends 2024
Synopsis
Porcine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease.
The global Porcine Epidemic Diarrhea Vaccines market size is expected to reach US$ 244.7 million by 2029, growing at a CAGR of 6.9% from 2023 to 2029. The market is mainly driven by the significant applications of Porcine Epidemic Diarrhea Vaccines in various end use industries. The expanding demands from the Piglets and Adults Pigs, are propelling Porcine Epidemic Diarrhea Vaccines market. Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Porcine Epidemic Diarrhea Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Porcine Epidemic Diarrhea Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Porcine Epidemic Diarrhea Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Porcine Epidemic Diarrhea Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Porcine Epidemic Diarrhea Vaccines covered in this report include CAVAC, Green Cross Veterinary Products, Harrisvaccines, Komipharm, Nisseiken, Qilu Animal Health and Zoetis, etc.
The global Porcine Epidemic Diarrhea Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CAVAC
Green Cross Veterinary Products
Harrisvaccines
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Global Porcine Epidemic Diarrhea Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Porcine Epidemic Diarrhea Vaccines market, Segment by Type:
Live Vaccines
Killed Vaccines
Global Porcine Epidemic Diarrhea Vaccines market, by Application
Piglets
Adults Pigs
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Porcine Epidemic Diarrhea Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Porcine Epidemic Diarrhea Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Porcine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease.
The global Porcine Epidemic Diarrhea Vaccines market size is expected to reach US$ 244.7 million by 2029, growing at a CAGR of 6.9% from 2023 to 2029. The market is mainly driven by the significant applications of Porcine Epidemic Diarrhea Vaccines in various end use industries. The expanding demands from the Piglets and Adults Pigs, are propelling Porcine Epidemic Diarrhea Vaccines market. Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Porcine Epidemic Diarrhea Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Porcine Epidemic Diarrhea Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Porcine Epidemic Diarrhea Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Porcine Epidemic Diarrhea Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Porcine Epidemic Diarrhea Vaccines covered in this report include CAVAC, Green Cross Veterinary Products, Harrisvaccines, Komipharm, Nisseiken, Qilu Animal Health and Zoetis, etc.
The global Porcine Epidemic Diarrhea Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CAVAC
Green Cross Veterinary Products
Harrisvaccines
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Global Porcine Epidemic Diarrhea Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Porcine Epidemic Diarrhea Vaccines market, Segment by Type:
Live Vaccines
Killed Vaccines
Global Porcine Epidemic Diarrhea Vaccines market, by Application
Piglets
Adults Pigs
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Porcine Epidemic Diarrhea Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Porcine Epidemic Diarrhea Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Porcine Epidemic Diarrhea Vaccines Market Overview
1.1 Porcine Epidemic Diarrhea Vaccines Product Overview
1.2 Porcine Epidemic Diarrhea Vaccines Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Porcine Epidemic Diarrhea Vaccines Market Size by Type
1.3.1 Global Porcine Epidemic Diarrhea Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Porcine Epidemic Diarrhea Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Type (2018-2023)
2 Global Porcine Epidemic Diarrhea Vaccines Market Competition by Company
2.1 Global Top Players by Porcine Epidemic Diarrhea Vaccines Sales (2018-2023)
2.2 Global Top Players by Porcine Epidemic Diarrhea Vaccines Revenue (2018-2023)
2.3 Global Top Players by Porcine Epidemic Diarrhea Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Porcine Epidemic Diarrhea Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Porcine Epidemic Diarrhea Vaccines Market Competitive Situation and Trends
2.5.1 Porcine Epidemic Diarrhea Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Porcine Epidemic Diarrhea Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Porcine Epidemic Diarrhea Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Porcine Epidemic Diarrhea Vaccines Market
2.8 Key Manufacturers Porcine Epidemic Diarrhea Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Porcine Epidemic Diarrhea Vaccines Status and Outlook by Region
3.1 Global Porcine Epidemic Diarrhea Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Porcine Epidemic Diarrhea Vaccines Historic Market Size by Region
3.2.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Porcine Epidemic Diarrhea Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Porcine Epidemic Diarrhea Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Region
3.3.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Porcine Epidemic Diarrhea Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Porcine Epidemic Diarrhea Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Porcine Epidemic Diarrhea Vaccines by Application
4.1 Porcine Epidemic Diarrhea Vaccines Market Segment by Application
4.1.1 Piglets
4.1.2 Adults Pigs
4.2 Global Porcine Epidemic Diarrhea Vaccines Market Size by Application
4.2.1 Global Porcine Epidemic Diarrhea Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Porcine Epidemic Diarrhea Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Application (2018-2023)
5 North America Porcine Epidemic Diarrhea Vaccines by Country
5.1 North America Porcine Epidemic Diarrhea Vaccines Historic Market Size by Country
5.1.1 North America Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Porcine Epidemic Diarrhea Vaccines Sales in Value by Country (2018-2023)
5.2 North America Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Country
5.2.1 North America Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Porcine Epidemic Diarrhea Vaccines Sales in Value by Country (2024-2029)
6 Europe Porcine Epidemic Diarrhea Vaccines by Country
6.1 Europe Porcine Epidemic Diarrhea Vaccines Historic Market Size by Country
6.1.1 Europe Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Porcine Epidemic Diarrhea Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Country
6.2.1 Europe Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Porcine Epidemic Diarrhea Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Porcine Epidemic Diarrhea Vaccines by Region
7.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales in Value by Region (2024-2029)
8 Latin America Porcine Epidemic Diarrhea Vaccines by Country
8.1 Latin America Porcine Epidemic Diarrhea Vaccines Historic Market Size by Country
8.1.1 Latin America Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Porcine Epidemic Diarrhea Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Country
8.2.1 Latin America Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Porcine Epidemic Diarrhea Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Porcine Epidemic Diarrhea Vaccines by Country
9.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CAVAC
10.1.1 CAVAC Company Information
10.1.2 CAVAC Introduction and Business Overview
10.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Products Offered
10.1.5 CAVAC Recent Development
10.2 Green Cross Veterinary Products
10.2.1 Green Cross Veterinary Products Company Information
10.2.2 Green Cross Veterinary Products Introduction and Business Overview
10.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Products Offered
10.2.5 Green Cross Veterinary Products Recent Development
10.3 Harrisvaccines
10.3.1 Harrisvaccines Company Information
10.3.2 Harrisvaccines Introduction and Business Overview
10.3.3 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Products Offered
10.3.5 Harrisvaccines Recent Development
10.4 Komipharm
10.4.1 Komipharm Company Information
10.4.2 Komipharm Introduction and Business Overview
10.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Komipharm Porcine Epidemic Diarrhea Vaccines Products Offered
10.4.5 Komipharm Recent Development
10.5 Nisseiken
10.5.1 Nisseiken Company Information
10.5.2 Nisseiken Introduction and Business Overview
10.5.3 Nisseiken Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Nisseiken Porcine Epidemic Diarrhea Vaccines Products Offered
10.5.5 Nisseiken Recent Development
10.6 Qilu Animal Health
10.6.1 Qilu Animal Health Company Information
10.6.2 Qilu Animal Health Introduction and Business Overview
10.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Products Offered
10.6.5 Qilu Animal Health Recent Development
10.7 Zoetis
10.7.1 Zoetis Company Information
10.7.2 Zoetis Introduction and Business Overview
10.7.3 Zoetis Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Zoetis Porcine Epidemic Diarrhea Vaccines Products Offered
10.7.5 Zoetis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Porcine Epidemic Diarrhea Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Porcine Epidemic Diarrhea Vaccines Industrial Chain Analysis
11.4 Porcine Epidemic Diarrhea Vaccines Market Dynamics
11.4.1 Porcine Epidemic Diarrhea Vaccines Industry Trends
11.4.2 Porcine Epidemic Diarrhea Vaccines Market Drivers
11.4.3 Porcine Epidemic Diarrhea Vaccines Market Challenges
11.4.4 Porcine Epidemic Diarrhea Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Porcine Epidemic Diarrhea Vaccines Distributors
12.3 Porcine Epidemic Diarrhea Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
